Optimizing evidence-based HIV prevention targeting people who inject drugs on PrEP
针对 PrEP 注射吸毒者优化基于证据的艾滋病毒预防
基本信息
- 批准号:10818897
- 负责人:
- 金额:$ 39.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAdherenceAreaAttentionBehaviorBehavior TherapyBehavioralBehavioral ResearchBrainCessation of lifeClinicClinicalCognitiveCompensationComplementDataData SetDevelopmentDorsalEducationEducational process of instructingEligibility DeterminationEnrollmentEpidemicExposure toFunctional Magnetic Resonance ImagingFunctional disorderFundingHIV riskImpaired cognitionIndividualIndividual DifferencesInjecting drug userInterventionLearningLiteratureMethodsMotorNeedle SharingNetwork-basedNeurosciencesOutcomeOutcome MeasureOverdoseParentsParticipantPatientsPatternPerformancePopulationPreventionPrevention approachProcessPsyche structurePublic HealthRelapseReproducibilityRestRewardsRisk BehaviorsRisk ReductionScanningSensorySpecific qualifier valueTestingTrainingUnited StatesUnsafe SexValidationWorkbrain basedbrain behaviorcognitive controlcognitive functioncognitive taskcombatconnectome based predictive modelingdesignevidence baseexecutive functionfunctional MRI scanhigh risk behaviorillicit opioidindependent component analysisinformation processinginsightinterestmedication for opioid use disordermemory processmortality riskmultiphase optimization strategyneuralneuroimagingneuromechanismopioid epidemicopioid useparent grantpatient populationpre-exposure prophylaxispredicting responsepreventive interventionrecruitresponseskillstreatment effect
项目摘要
The proposed 4-year Supplement project will incorporate functional magnetic resonance imaging (fMRI) into
a recently funded multiphase optimization strategy (MOST) trial of a Pre-Exposure Prophylaxis (PrEP)-
focused intervention for people who inject drugs (PWID) who are newly enrolled in medication for opioid
use disorder (MOUD) treatment (R01DA055534; Copenhaver, PI). The scientific premise for this
supplement builds directly on evidence summarized in the parent grant - that cognitive dysfunction is
common among PWID and disrupts PrEP-focused HIV prevention outcomes, if not properly
accommodated. The neuroimaging battery will include tasks of specific relevance to cognitive dysfunction
and to PrEP and MOUD outcomes as well as data specifically acquired during exposure to PrEP educational
videos and during resting state. Based on our prior work conducted in the same MOUD clinics as the parent
trial, we anticipate that ~80% of individuals enrolled in the parent trial will be interested in and eligible for
fMRI scanning. Thus, we anticipate scanning approximately 200 individuals over 4-years, with the following
aims: (1) Specifying brain-based mechanisms of cognitive dysfunction among individuals entering PrEP-
focused intervention. During fMRI scanning, participants will complete cognitive function tasks with specific
relevance to compensatory intervention components being tested in the parent trial (i.e., validated tasks of
cognitive/executive function,, attention, memory, and information processing). Data will be analyzed using
advanced, network-based approaches (e.g., independent component analysis) to provide the first ever
comprehensive characterization of neural processes subserving cognitive dysfunction among PWID entering
MOUD and PrEP, and (2) Identifying predictive neuromarkers of return to risk behaviors (i.e., PrEP and
MOUD outcomes). We will use an interpretable, connectivity-based approach, connectome-based predictive
modeling (CPM), to identify predictive neuromarkers of PrEP and MOUD outcomes. The proposed
supplemental work will provide mechanistic insight into clinical individual difference factors among
individuals with multiple high-risk behaviors (e.g., condomless sex, needle sharing) among individuals in
MOUD, and is an essential precursor to the development of optimized, biologically based, prevention and
intervention efforts to combat the current opioid epidemic.
拟议的4年补充项目将把功能性磁共振成像(fMRI)纳入
最近资助的暴露前预防(PrEP)多阶段优化策略(MOST)试验-
对新登记接受阿片类药物治疗的注射毒品者(PWID)进行重点干预
使用障碍(MOUD)治疗(R 01 DA 055534; Copenhaver,PI)。科学的前提是
补充直接建立在父母补助金中总结的证据上-认知功能障碍是
在PWID中很常见,如果不适当,则会破坏以PrEP为重点的艾滋病毒预防结果
很好神经成像成套测验将包括与认知功能障碍具体相关的任务
以及PrEP和MOUD结果以及在暴露于PrEP教育期间专门获取的数据
视频和休息状态下。基于我们之前在与母公司相同的MOUD诊所进行的工作
我们预计,约80%的入组母试验的个体将对以下项目感兴趣并有资格
功能磁共振扫描因此,我们预计在4年内扫描约200人,
目的:(1)进入PrEP的个体中认知功能障碍的脑机制-
集中干预。在fMRI扫描期间,参与者将完成特定的认知功能任务,
与母试验中测试的补偿性干预成分的相关性(即,验证任务
认知/执行功能、注意力、记忆和信息处理)。将使用以下方法分析数据:
先进的、基于网络的方法(例如,独立成分分析(Independent Component Analysis)
PWID患者认知功能障碍的神经过程的综合表征
MOUD和PrEP,以及(2)识别回归风险行为的预测性神经标志物(即,准备和
MOUD成果)。我们将使用一种可解释的、基于连接性的方法,
模型(CPM),以确定PrEP和MOUD结果的预测性神经标志物。拟议
补充工作将提供对临床个体差异因素的机械洞察,
具有多种高风险行为的个体(例如,无安全套性行为,共用针头)的情况,
MOUD,并且是开发优化的、基于生物学的预防和
采取干预措施,打击目前的阿片类药物流行病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL COPENHAVER其他文献
MICHAEL COPENHAVER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL COPENHAVER', 18)}}的其他基金
Optimizing evidence-based HIV prevention targeting people who inject drugs on PrEP
针对 PrEP 注射吸毒者优化基于证据的艾滋病毒预防
- 批准号:
10548320 - 财政年份:2022
- 资助金额:
$ 39.53万 - 项目类别:
Optimizing HIV Prevention Among Opioid-Dependent Persons
优化阿片类药物依赖者的艾滋病毒预防
- 批准号:
10425302 - 财政年份:2020
- 资助金额:
$ 39.53万 - 项目类别:
Optimizing HIV Prevention Among Opioid-Dependent Persons
优化阿片类药物依赖者的艾滋病毒预防
- 批准号:
10652562 - 财政年份:2020
- 资助金额:
$ 39.53万 - 项目类别:
Optimizing HIV Prevention Among Opioid-Dependent Persons
优化阿片类药物依赖者的艾滋病毒预防
- 批准号:
10217091 - 财政年份:2020
- 资助金额:
$ 39.53万 - 项目类别:
Optimizing HIV Prevention Among Opioid-Dependent Persons
优化阿片类药物依赖者的艾滋病毒预防
- 批准号:
10083001 - 财政年份:2020
- 资助金额:
$ 39.53万 - 项目类别:
Testing an integrated bio-behavioral primary HIV prevention intervention among high-risk people who use drugs
在吸毒高危人群中测试综合生物行为艾滋病毒初级预防干预措施
- 批准号:
10197074 - 财政年份:2017
- 资助金额:
$ 39.53万 - 项目类别:
Testing an integrated bio-behavioral primary HIV prevention intervention among high-risk people who use drugs
在吸毒高危人群中测试综合生物行为艾滋病毒初级预防干预措施
- 批准号:
9410858 - 财政年份:2017
- 资助金额:
$ 39.53万 - 项目类别:
HIV Prevention and Adherence Among Priority Drug Using Populations
优先吸毒人群的艾滋病毒预防和依从性
- 批准号:
8628827 - 财政年份:2013
- 资助金额:
$ 39.53万 - 项目类别:
HIV Prevention and Adherence Among Priority Drug Using Populations
优先吸毒人群的艾滋病毒预防和依从性
- 批准号:
8812787 - 财政年份:2013
- 资助金额:
$ 39.53万 - 项目类别:
HIV Prevention and Adherence Among Priority Drug Using Populations
优先吸毒人群的艾滋病毒预防和依从性
- 批准号:
8541232 - 财政年份:2013
- 资助金额:
$ 39.53万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 39.53万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 39.53万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 39.53万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 39.53万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 39.53万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 39.53万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 39.53万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 39.53万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 39.53万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 39.53万 - 项目类别:
Fellowship Programs














{{item.name}}会员




